Rotech Healthcare Inc.: Represented an ad hoc group of first lien lenders, including Silver Point Finance, LLC and Capital Research & Management Company, in Rotech’s ongoing chapter 11 case.

Hanger Orthopedic Group/NovaCare Orthotics and Prosthetics, Inc.: Represented bridge loan commitment and 144A offering of $150 million of senior subordinated notes of Hanger in connection with its acquisition of NovaCare.

Platinum Equity: Represented Platinum Equity in the financing of its $2.1 billion acquisition of LifeScan Diagnostic Systems’ manufacturing business.

PerkinElmer, Inc.: Advised on a transaction involving a $350 million cross-border financing for PerkinElmer, a global provider of advanced technology solutions.

ReAble Therapeutics: Provided senior executive representation for ReAble, a leading medical device company in the rehabilitation and orthopedics markets.

PerkinElmer, Inc.: Advised on a transaction involving a $350 million cross-border financing for Massachusetts-based PerkinElmer, a global provider of advanced technology solutions that address critical health and safety concerns, and its subsidiaries.

Platinum Equity/Pelican Products: Acted as financing legal counsel for Platinum Equity in its acquisition of Pelican Products, a leading designer and manufacturer of high-performance protective cases and rugged gear, and temperature-controlled supply chain solutions for the healthcare industry.

Johnson & Johnson: Successfully represented this multinational manufacturer of healthcare, personal hygiene and pharmaceutical products.

Medical Devices: Represented a leading manufacturer of medical devices in multiple patent infringement cases.

Medical Devices: Represented a medical device manufacturer in a lawsuit for trade secret misappropriation and patent infringement. The plaintiff voluntarily dismissed his patent infringement claim with prejudice rather than defend against a motion for summary judgment of patent invalidity. The Sixth Circuit then unanimously affirmed the grant of summary judgment of no trade secret misappropriation.

Philips Medical Systems: Successfully represented Philips Medical Systems in enforcing and defending against 21 patents relating to several different facets of automatic external defibrillator (AED) technology.

AdaptHealth/AeroCare: Represented AdaptHealth Corp. in its $2 billion acquisition of home medical equipment provider AeroCare.

AdaptHealth/DFB Healthcare: Represented home medical equipment company AdaptHealth in its business combination with special purpose acquisition company DFB Healthcare Acquisitions Corp.

AdaptHealth/Solara/ActivStyle: Represented AdaptHealth in its equity investments from One Equity Partners and Deerfield Management in connection with AdaptHealth’s acquisitions of Solara Medical Supplies, LLC and ActivStyle, Inc.

Court Square Capital Partners/Medical Knowledge Group/Novo Holdings: Represented Court Square Capital Partners on the sale of Medical Knowledge Group to Novo Holdings.

Court Square Capital Partners/WindRose Health Investors/Medical Knowledge Group: Represented Court Square Capital Partners in the recapitalization and acquisition of Medical Knowledge Group from WindRose Health Investors.

CVC/Sebia: Represented CVC Capital Partners Strategic Opportunities (CVC Stratops) on its acquisition, alongside Téthys Invest, of a controlling stake in Sebia from Astorg and Montagu Private Equity.

exocad GmbH/The Carlyle Group: Represented the shareholders of exocad GmbH, an independent developer of dental software solutions, in the sale of a majority stake to The Carlyle Group as well as certain shareholders on their reinvestment.

Galil Medical/BTG: Represented certain shareholders of cryotherapy company Galil Medical in its sale to BTG plc.

GHO Capital/Sanner Group: Represented GHO Capital on its investment in Sanner Group.

Hansen Medical/Auris Surgical Robots: Advised funds owned by Oracle Management and other majority stockholders of Hansen Medical, Inc. in the acquisition of Hansen Medical by Auris Surgical Robotics, Inc., as well as the related re-investment by such stockholders of their proceeds into Auris.

HealthEquity/Luum: Represented HealthEquity in its acquisition of Luum, a technology platform for employee commute management.

IK Investment Partners/Marle: Represented IK Investment Partners in its agreement to acquire orthopedic implant manufacturing company Marle from The Carlyle Group.

IK Investment Partners and The Carlyle Group/Marle: Represented IK Investment Partners and The Carlyle on the sale of orthopedic implant manufacturing company Marle to Dentressangle.

Insight Venture Partners/CentralReach: Represented Insight Venture Partners in its significant investment in electronic health record and practice management provider CentralReach.

Insight Partners/Nordic Capital/22C Capital/Inovalon: Represented Insight Partners as lead co-investor in an equity consortium in an agreement to acquire Inovalon for $7.3 billion.

Insightful Science/Dotmatics: Represented Insightful Science, a portfolio company of Insight Partners, in its acquisition of Dotmatics, a scientific informatics software and services company.

Intermediate Capital Group/Biogroup: Represented ICG Europe VII, an affiliate of Intermediate Capital Group, in its investment in Biogroup, a leading French operator of medical diagnostic laboratories.

Kinnser Software/Insight Venture Partners/Mediware: Represented Kinnser Software, Inc., the leading provider of software solutions for home health and hospice providers, and Insight Venture Partners in the sale of Kinnser to TPG Capital-backed Mediware Information Systems, Inc.  

New Mountain Capital/Sparta Systems/Honeywell: Represented New Mountain Capital portfolio company Sparta Systems in New Mountain’s $1.3 billion sale of Sparta to Honeywell.

PAI Partners/Amplitude Surgical: Represented PAI Partners in connection with its contemplated acquisition of a majority stake in Euronext listed Amplitude Surgical, a French leader on the global surgical technology market for lower-limb orthopedics.

PAI Partners/ELITech: Represented PAI Partners in its acquisition of ELITech Group, a leading manufacturer of specialty in-vitro diagnostics equipment and reagents, from Ergon Capital.

Qualium Investissement/IMV Technologies: Represented Qualium Investissement on its announced sale of its majority stake in IMV Technologies to Montagu Private Equity.

RevSpring/Loyale Healthcare: Represented Loyale Healthcare, a leading provider of patient payment and engagement solutions, in its acquisition by RevSpring.

Sagard/Sterimed: Represented Sagard in its acquisition of Sterimed, a leading manufacturer of sterile packaging for the pharmaceutical industry, from Meeschaert Capital Partners.

Salient CRGT/Information Innovators: Represented Bridge Growth Partners, LLC and Salient CRGT in Salient CRGT’s acquisition of Information Innovators, Inc., a technology and mission-focused company serving the federal government, with particular strength in the healthcare IT arena.

Sebia/ORGENTEC Diagnostika: Represented Sebia on the acquisition of specialty diagnostic leader ORGENTEC Diagnostika from Water Street Healthcare Partners.

The CapStreet Group/Surgical Notes: Represented CapStreet in the completion of its majority recapitalization of Surgical Notes LLC, a group of Texas-based companies that provide healthcare coding and billing services.

Valtech Cardio/Edwards Lifesciences Corporation: Represented Valtech Cardio in its acquisition by Edwards Lifesciences Corporation for up to $690 million. 

Virgin Pulse/Marlin Equity Partners: Represented Virgin Pulse in its sale to Marlin Equity Partners.  

Voalte/Hill-Rom: Represented Voalte, a pioneer and leader in real-time, mobile healthcare communications, in its sale to global medical technology company Hill-Rom for $180 million.

Warburg Pincus/Aircast, Inc.: Represented Warburg and Credit Suisse First Boston in connection with investments in this leading global provider.

WebPT/Warburg Pincus/Clinicient: Represented WebPT, a portfolio company of Warburg Pincus, in its acquisition of Clinicient.